SynthesisPloS one2011

Excision repair cross-complementation group 1 (ERCC1) status and lung cancer outcomes: a meta-analysis of published studies and recommendations.

Richard A Hubner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.